UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.317

Sortiert nach

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

Acta psychiatrica Scandinavica, 2003-05, Vol.107 (s416), p.16-23

2003

Volltextzugriff (PDF)

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan

Breast cancer (Tokyo, Japan), 2023-07, Vol.30 (4), p.657-665

2023

Volltextzugriff (PDF)

Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia

Acta psychiatrica Scandinavica, 2008-09, Vol.118 (3), p.220-229

2008

Volltextzugriff (PDF)

2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery

European neuropsychopharmacology, 2011-04, Vol.21 (4), p.287-293

2011

Volltextzugriff (PDF)

Obesity as a Correlate of Outcome in Patients With Bipolar I Disorder

The American journal of psychiatry, 2003-01, Vol.160 (1), p.112-117

2003

Volltextzugriff (PDF)

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients

International journal of clinical practice (Esher), 2009-11, Vol.63 (11), p.1578-1588

2009

Volltextzugriff (PDF)

Assessment of medication adherence in a cohort of patients with bipolar disorder

Pharmacopsychiatry, 2010-11, Vol.43 (7), p.263

2010

Volltextzugriff (PDF)

The human interferon α/β receptor : characterization and molecular cloning

Cell, 1994-05, Vol.77 (3), p.391-400

1994

Volltextzugriff (PDF)

Impact of pain and remission in the functioning of patients with depression in China

European psychiatry, 2016-03, Vol.33 (S1), p.S419-S419

2016

Volltextzugriff (PDF)

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

The New England journal of medicine, 2021-12, Vol.385 (23), p.2140-2149

2021

Volltextzugriff (PDF)

Adult Langerhans cell histiocytosis: a rare cause of colon polyp

Endoscopy, 2009, Vol.41 Suppl 2, p.E160

2009

Volltextzugriff (PDF)

Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study

Acta psychiatrica Scandinavica, 2005-03, Vol.111 (3), p.220-231

2005

Volltextzugriff (PDF)

Predictors of the course of illness in outpatients with schizophrenia: A prospective three year study

Progress in neuro-psychopharmacology & biological psychiatry, 2008-07, Vol.32 (5), p.1287-1292

2008

Volltextzugriff (PDF)

P.3.d.060 Comparative clinical outcomes of orodispersable versus standard oral olanzapine tablets in non-adherent patients with schizophrenia or bipolar disorder

European neuropsychopharmacology, 2015-09, Vol.25, p.S514-S515

2015

Volltextzugriff (PDF)

Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database

Spine (Philadelphia, Pa. 1976), 2013-01, Vol.38 (1), p.75-82

2013

Volltextzugriff (PDF)

Relationship of Insight with Medication Adherence and the Impact on Outcomes in Patients with Schizophrenia and Bipolar Disorder: Results From A 1-Year European Outpatient Observational Study

Value in health, 2014-11, Vol.17 (7), p.A455-A455

2014

Volltextzugriff (PDF)

Symtomatic Factors in Patients With Major Depressive Disorder (MDD): Results from an Observational Study

Value in health, 2014-11, Vol.17 (7), p.A543-A543

2014

Volltextzugriff (PDF)

Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients: Results from a 1-Year European Outpatient Observational Study

Value in health, 2014-11, Vol.17 (7), p.A766-A766

2014

Volltextzugriff (PDF)

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia

Journal of pain research, 2014-01, Vol.7 (default), p.37-46

2014

Volltextzugriff (PDF)

PMS13 Medication Adherence and Health Care Costs among Patients with Osteoarthritis Initiating Duloxetine Versus Celecoxib

Value in health, 2012-06, Vol.15 (4), p.A35-A35

2012

Volltextzugriff (PDF)

PMS14 Health Care Costs and Opioid Use among Patients with Osteoarthritis Initiating Duloxetine Versus Other Treatments

Value in health, 2012-06, Vol.15 (4), p.A35-A36

2012

Volltextzugriff (PDF)

PSY14 Health Care Costs and Opioid Use among Patients With Chronic Low Back Pain Initiating Duloxetine Versus Other Treatments

Value in health, 2012-06, Vol.15 (4), p.A100-A101

2012

Volltextzugriff (PDF)

EPA-1096 - Impact of medication non-compliance on outcomes of asian patients with depression

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

EPA-1095 - Impact of pain on the outcomes of depression across age and gender groups in china

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

EPA-1087 - Treatment patterns in asian patients with a major depressive episode

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

1 – 25 von 1.317

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.195)
Mit Volltextzugriff
(969)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(779)
Life Sciences & Biomedicine
(672)
Humans
(637)
Biological And Medical Sciences
(397)
Female
(361)
Male
(356)
Medical Sciences
(338)
Adult
(270)
Middle Aged
(254)
Surgery
(166)
Aged
(157)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(133)
Immunology
(111)
Animals
(107)
Adolescent
(100)
Urology & Nephrology
(92)
Kidney Transplantation
(90)
Cardiovascular System & Cardiology
(87)
Time Factors
(83)
Child
(82)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan

Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia

2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery

Obesity as a Correlate of Outcome in Patients With Bipolar I Disorder

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients

Assessment of medication adherence in a cohort of patients with bipolar disorder

The human interferon α/β receptor : characterization and molecular cloning

Impact of pain and remission in the functioning of patients with depression in China

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

Adult Langerhans cell histiocytosis: a rare cause of colon polyp

Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study

Predictors of the course of illness in outpatients with schizophrenia: A prospective three year study

P.3.d.060 Comparative clinical outcomes of orodispersable versus standard oral olanzapine tablets in non-adherent patients with schizophrenia or bipolar disorder

Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database

Relationship of Insight with Medication Adherence and the Impact on Outcomes in Patients with Schizophrenia and Bipolar Disorder: Results From A 1-Year European Outpatient Observational Study

Symtomatic Factors in Patients With Major Depressive Disorder (MDD): Results from an Observational Study

Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients: Results from a 1-Year European Outpatient Observational Study

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia

PMS13 Medication Adherence and Health Care Costs among Patients with Osteoarthritis Initiating Duloxetine Versus Celecoxib

PMS14 Health Care Costs and Opioid Use among Patients with Osteoarthritis Initiating Duloxetine Versus Other Treatments

PSY14 Health Care Costs and Opioid Use among Patients With Chronic Low Back Pain Initiating Duloxetine Versus Other Treatments

EPA-1096 - Impact of medication non-compliance on outcomes of asian patients with depression

EPA-1095 - Impact of pain on the outcomes of depression across age and gender groups in china

EPA-1087 - Treatment patterns in asian patients with a major depressive episode

Suchergebnisse filtern